Nucleai
Avi Laniado currently serves as the Medical Data Project Lead at Nucleai, where the focus is on utilizing an AI-powered precision oncology platform to enhance biomarker discovery and inform treatment decisions, ultimately improving clinical trial outcomes and patient care. In addition to this role, Avi Laniado is a Medical Intern at Shamir Medical Center (Assaf Harofeh) since February 2024. Educationally, Avi Laniado is pursuing a Doctor of Medicine (MD) degree at Tel Aviv University, expected to be completed in 2024, and holds a Bachelor's degree in Dentistry from the same institution, completed in 2017.
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.